Aclidinium bromide: an alternative long-acting inhaled anticholinergic in the management of chronic obstructive pulmonary disease

• Published in: The Annals of pharmacotherapy Vol. 47; no. 7-8; p. 1017
• Main Authors: Woods, J Andrew, Nealy, Kimberly L, Barrons, Robert W
• Format: Journal Article
• Language: English
• Published: United States 01.07.2013
• Subjects: Administration, Inhalation; Animals; Bronchodilator Agents - administration & dosage; Cholinergic Antagonists - administration & dosage; Clinical Trials as Topic - methods; Disease Management; Forced Expiratory Volume - drug effects; Forced Expiratory Volume - physiology; Humans; Pulmonary Disease, Chronic Obstructive - diagnosis; Pulmonary Disease, Chronic Obstructive - drug therapy; Pulmonary Disease, Chronic Obstructive - physiopathology; Treatment Outcome; Tropanes - administration & dosage

To evaluate the efficacy and safety of aclidinium bromide, a novel, long-acting inhaled muscarinic receptor antagonist approved by the Food and Drug Administration (FDA) in July 2012, as a treatment in the management of moderate to severe chronic obstructive pulmonary disease (COPD). Literature was...